NOI: Notice of Intent to Sole Source
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98027Q00076
NAICS
622110 - General Medical and Surgical Hospitals
Classification Code
Q999
Additional Details
Documents1
This procurement notice announces the National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), intent to award a sole source contract to Johns Hopkins Bayview Medical Center, Inc. The contract is designed to extend the period of performance for critical clinical services and resources that support the ongoing research operations of the National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) Clinical Research Program. The proposed extension will cover a twelve-month period, specifically from December 31, 2026, through January 31, 2027.
The primary objective of this procurement is to ensure the uninterrupted provision of specialized clinical services and resources essential for the maintenance and advancement of NIDA’s clinical research activities. These services are integral to the operation of the NIDA IRP Clinical Research Program, which relies on a stable and highly qualified clinical environment to conduct its research initiatives. The expected deliverables include the continued availability of clinical infrastructure, personnel, and support necessary to facilitate ongoing and future research projects within the program.
This action is being taken as a sole source procurement, as determined by the results of market research conducted by the Government. The findings indicate that Johns Hopkins Bayview Medical Center is uniquely positioned as the only vendor capable of meeting the specific requirements of the NIDA IRP Clinical Research Program. As such, the Government will not be soliciting offers from other sources, and full and open competition requirements have been waived for this extension.
The procurement is classified under NAICS code 622110 (General Medical and Surgical Hospitals), as per the 2022 NAICS version, and is further identified by Product Service Code Q999. The contracting activity is managed by the NIH OLAO, a federal office within the Department of Health and Human Services. The primary point of contact for this notice is John R. Johnson, who can be reached via email at [email protected].
Interested parties should note that this is a Notice of Intent (NOI) to award on a sole source basis, and the opportunity is currently active. The official response deadline is November 25, 2026, at 19:11. Additional details and the official notice can be accessed through the SAM.gov opportunity ID 702e57f349184a10962f5e0aaa7ef73b.
Contractors considering this opportunity should be aware that the scope, requirements, and deliverables are highly specialized and tailored to the ongoing needs of the NIDA IRP Clinical Research Program. The contract is not set aside for small businesses or other socioeconomic programs, and the sole source determination is based on the unique capabilities of the selected vendor. This procurement ensures continuity of critical research operations and supports the NIH’s mission to advance scientific knowledge in the field of drug abuse and addiction.